Advertisement

Topics

Latest "LithoLink Corporation" News Stories - Page: 19

14:18 EST 22nd January 2019 | BioPortfolio

Here are the most relevant search results for "LithoLink Corporation" found in our extensive news archives from over 250 global news sources.

More Information about LithoLink Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about LithoLink Corporation for you to read. Along with our medical data and news we also list LithoLink Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of LithoLink Corporation Companies for you to search.

Showing "LithoLink Corporation" News Articles 451–475 of 669

Possibly Relevant

FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

F. Hoffmann-La Roche Ltd / FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Approval based on survival benefit of Tecentriq in combination with...


Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London

Novartis International AG / Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registratio...

FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for initial treatment of metastatic non-squamous non-small cell lung cancer

F. Hoffmann-La Roche Ltd / FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for initial treatment of metastatic non-squamous non-small cell lung cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, 17 January 2019 - Roc...


Tenet Reports Results for the Third Quarter Ended September 30, 2018

Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $9 million or $0.09 per diluted share in the third quarter of 2018 compared to a net loss of $366 million or $3.63 per diluted share in the third quarter of 2017. After adjusting for certain items, which totaled $39 million or $0.38 per share in...

Global Nuclear Medicine Market Segmented by Diagnostics, Therapeutics, Application and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

Nuclear medicine falls under the field of molecular imaging, which involves the usage of very small amount of radioactive material radiopharmaceuticals to diagnose and treat disease. In nuclear medicine imaging, the radioisotopes are detected by the special type of cameras attached to the computer, which, in turn, provide very precise pictures of the area of the body examined. The global nuclear m...

Global Nuclear Medicine Market Segmented by Diagnostics, Therapeutics, Application and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

Nuclear medicine falls under the field of molecular imaging, which involves the usage of very small amount of radioactive material radiopharmaceuticals to diagnose and treat disease. In nuclear medicine imaging, the radioisotopes are detected by the special type of cameras attached to the computer, which, in turn, provide very precise pictures of the area of the body examined. The global nuclear m...

Global Medical Alert System/Personal Emergency Response System Market Segmented by Type, EndUser and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

Personal emergency response systems PERS, also known as medical emergency response systems, allow users to call for help when in an emergency by pushing a button. It has three components: a small radio transmitter, a console connected to the telephone, and an emergency response center that monitors calls. The global medical alert system/personal emergency response system market is expected to regi...

CEL-SCI Corporation Reports Third Quarter Fiscal Year 2018 Financial Results

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2018. The Company also reported key clinical and corporate developments achieved during the quarter. Clinical and Corporate Developments included: CEL-SCI’s Phase 3 head and neck cancer study continued to follow all 928 pa...

Global Surfactants Market Segmented by Origin, Type, Application, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global surfactants market is expected to register a CAGR of 5.41% during the forecast period, 2018 to 2023. AsiaPacific accounted for the largest market, with a market share of almost 40% of the global market in 2017.Growing Personal Care Industry in AsiaPacific Personal care is one of the major endusers for surfactants. Surfactants are used as ingredients such as foaming agents, dispersants, ...

Pixium Vision announces its PRIMA chip successfully met interim study endpoints for dry AMD

           Pixium Vision announces its wireless PRIMA chip successfully met the interim study endpoints for dry Age-related Macular Degeneration Implant is well tolerated while preserving residual peripheral visual acuity All subjects report light perception in their central visual field Majority of patients identifying complex patterns, letters or letter sequenc...

Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo® (pegfilgrastim)

Novartis International AG / Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo® (pegfilgrastim) . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Biosimilar Ziextenzo® (pegfilgrastim), a long-acting version of supportive oncology medicine filgrastim, is now approved for use i...

Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program

Novartis International AG / Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. New post-hoc analysis of SUSTAIN study, presented at ASH 2018, highlights results among patients who were ...

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2019

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae based, high-value nutrition and health products, announced financial results for the second quarter and first six months of fiscal year 2019, ended September 30, 2018. Second Quarter Fiscal 2019 For the second quarter of fiscal 2019 compared to the second qu...

North America ReadytoDrink RTD Coffee Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3850

The North American RTD coffee market is expected to be valued at USD 2.458 billion in 2018 and is expected to grow at a CAGR of 2.7% and mature into a USD 2.643 billion market by 2023. Readytodrink coffee is a recently developed concept wherein the beverage is sold in a convenient and directly consumable form. Despite being marketed as a young and urban phenomenon, RTD consumers can be from almost...

Global Genetic Testing Market Segmented by Treatment Type, Diseases, Technology and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

As of 2017, the global genetic testing market was valued at USD 9,367.0 million and is expected to record a CAGR of around 10.4% during 20182023 the forecast period. In 2017, the North American genetic testing segment of the market studied accounted for the highest revenue and AsiaPacific is expected to register the highest CAGR of 12.6% over the forecast periodGrowing Demand for Personalized Medi...

Global Food Betaine Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The global food betaine market is expected to register a CAGR of 5.9% during the forecast period, 20182023. Betaine has shown potential benefits for fighting heart disease, improving blood composition and helping promote muscle gain and fat loss. It can be prepared synthetically or from sugar beet molasses and is extensively used in food and personal care products.Market DynamicsThe rise in awaren...

Global Food Betaine Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global food betaine market is expected to register a CAGR of 5.9% during the forecast period, 20182023. Betaine has shown potential benefits for fighting heart disease, improving blood composition and helping promote muscle gain and fat loss. It can be prepared synthetically or from sugar beet molasses and is extensively used in food and personal care products.Market DynamicsThe rise in awaren...

Nicox Reaches 50% Enrollment Threshold in U.S. Phase 2 Study with NCX 470 Ahead of Schedule

Press ReleaseNicox Reaches 50% Enrollment Threshold in U.S. Phase 2 Study with NCX 470 Ahead of Schedule ...............................................January 8, 2019 - release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced it has reached the 50% patient enrollment threshold ...

GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis

GENFIT:  Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis Phase 2 study targeting a patient population with NASH-induced Stage 2 or 3 fibrosis Anti-fibrotic effect of nitazoxanide to be evaluated by several approaches including an innovative method to quantify hepatic fibrogenesis flux rates Lille (France), Camb...

Canada InVitro Diagnostics Market Segmented by Technique, by Product, by Applications, by End User Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3000

The Canada in vitro diagnostics market in emerging economies was estimated at USD 3,391.10 million in 2017. The market is expected to reach USD 5,890.54 million by 2023, at a CAGR of 9.64% during the forecast period, 20182023. Currently, North America dominates the global market, with the market yet to reach saturation. The Canada is the leading market both globally and in North America. Rapid A...

Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer

F. Hoffmann-La Roche Ltd / Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Entrectinib reduced tumours in people with ROS1-positive non-small cell lung cance...

DBV Technologies Appoints Daniel Tassé as Chief Executive Officer

Montrouge, France, November 16, 2018 DBV Technologies Appoints Daniel Tassé as Chief Executive Officer Daniel brings strong track record of building and leading global organizations and delivering transformative products to patients Co-founder Dr. Pierre-Henri Benhamou to retire as CEO and serve as Non-Executive Chairman of the Board DBV Technologies ...

Global Nucleic Acid Isolation and Purification NAIP Market Segmented by Technology, Application, Product, EndUsers and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global nucleic acid isolation and purification NAIP market is estimated to reach approximately USD 5,300 million by 2023, at a CAGR of about 9% during the forecast period. This market is segmented based on technology, product, application, end user, and geography. In the segmentation based on technology, columnbased purification has the largest market share, however, magnetic beadbased purific...

Global Nucleic Acid Isolation and Purification NAIP Market Segmented by Technology, Application, Product, EndUsers and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global nucleic acid isolation and purification NAIP market is estimated to reach approximately USD 5,300 million by 2023, at a CAGR of about 9% during the forecast period. This market is segmented based on technology, product, application, end user, and geography. In the segmentation based on technology, columnbased purification has the largest market share, however, magnetic beadbased purific...

Global Polystyrene Market Segmented by Resin Type, Form Type, EndUser Industry, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global polystyrene market has been estimated at USD 28,103.36 million in 2017. The market is expected to register a CAGR of 4.91% during the forecast period, 2018 to 2023. General Purpose Polystyrene dominated the global polystyrene market with nearly 25% share globally and is estimated to register the fastest CAGR through the forecast period. GROWING CONSUMER ELECTRONICS MARKET Consumer elect...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks